In particular, glutaminase, a key enzyme converting glutamine to glutamate, was found to be increased in several cell types, including osteoblasts [84] and, via HIF-1, in colorectal cancer cells, which required glutaminase for hypoxia-induced migration and invasion in vitro, and tumour growth and metastatic colonisation in vivo [85]. This evidence concerns the gene GLS and colorectal cancer.